Mao, Chenyu
Xiong, Anwen
Qian, Jiong
Wang, Wenxiang
Liu, Ying
Zhang, Tao
Wu, Zhihai
Ni, Haiqing
Lu, Jia
Long, Sixiang
Zhao, Li
Chen, Yuling
Zhou, Caicun
Xu, Nong
Funding for this research was provided by:
Innovent Biologics (Suzhou) Co., Ltd (N/A)
Article History
Received: 15 October 2024
Accepted: 12 December 2024
First Online: 31 December 2024
Declarations
:
: The study protocol was approved by the institutional review board and ethics committee of all participating sites. This study was registered at clinicaltrials.gov (NCT04085185) and conducted following Good Clinical Practice Guidelines, the Declaration of Helsinki, and relevant local regulatory policy. Written informed consents were required before patient enrollment.
: The authors declare no competing interests.